Last reviewed · How we verify
Raxtozinameran 6 months to 4 years of age (raxtozinameran-6-months-to-4-years-of-age)
Raxtozinameran 6 months to 4 years of age (generic name: raxtozinameran-6-months-to-4-years-of-age) is a viral entry inhibitor drug developed by Pfizer. It is currently FDA-approved for COVID-19 prevention.
Raxtozinameran is a COVID-19 prevention medication developed by Pfizer Inc. It works by targeting the SARS-CoV-2 virus. Raxtozinameran is a key indication for COVID-19 prevention. It has significant commercial value, generating $21.2B in revenue. The drug's mechanism and clinical differentiation set it apart from other treatments. Raxtozinameran's pipeline developments are not publicly available. As a marketed drug, it has undergone clinical trials.
At a glance
| Generic name | raxtozinameran-6-months-to-4-years-of-age |
|---|---|
| Sponsor | Pfizer |
| Drug class | viral entry inhibitor |
| Target | SARS-CoV-2 virus |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- COVID-19 prevention
Common side effects
Drug interactions
- Warfarin
- P-glycoprotein inducers (e.g., rifampin, carbamazepine, phenytoin)
- P-glycoprotein inhibitors (e.g., verapamil, quinidine, ketoconazole)
- CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin)
- CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir)
- Other immunosuppressants (e.g., cyclosporine, tacrolimus)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Raxtozinameran 6 months to 4 years of age CI brief — competitive landscape report
- Raxtozinameran 6 months to 4 years of age updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Raxtozinameran 6 months to 4 years of age
What is Raxtozinameran 6 months to 4 years of age?
What is Raxtozinameran 6 months to 4 years of age used for?
Who makes Raxtozinameran 6 months to 4 years of age?
What is the generic name of Raxtozinameran 6 months to 4 years of age?
What drug class is Raxtozinameran 6 months to 4 years of age in?
What development phase is Raxtozinameran 6 months to 4 years of age in?
What does Raxtozinameran 6 months to 4 years of age target?
Related
- Drug class: All viral entry inhibitor drugs
- Target: All drugs targeting SARS-CoV-2 virus
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for COVID-19 prevention
- Compare: Raxtozinameran 6 months to 4 years of age vs similar drugs
- Pricing: Raxtozinameran 6 months to 4 years of age cost, discount & access